Management and Executive

Associate Director Technical CMC Operations

US FDA Gives Positive Feedback on PharmaEssentia's Cancer Drug Trial Request

Taiwania Capital Management Corporation Portfolio - PharmaEssentia

PharmaEssentia to Participate at Morgan Stanley 23rd Annual Global Healthcare Conference

Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia

Director, Health Economics and Outcomes Research (HEOR)

PharmaEssentia USA is a rapidly growing biopharmaceutical innovator focused on delivering effective new biologics for hematology and oncology. The Director of Health Economics and Outcomes Research (HEOR) will develop and implement the US HEOR strategy, engage with healthcare stakeholders, and drive evidence generation projects to support market access.

Sign up with Google

Sign in with Google